rdf:type |
|
lifeskim:mentions |
umls-concept:C0002210,
umls-concept:C0008059,
umls-concept:C0036525,
umls-concept:C0206624,
umls-concept:C0441889,
umls-concept:C0449243,
umls-concept:C0684224,
umls-concept:C1274040,
umls-concept:C1516476,
umls-concept:C1519810,
umls-concept:C1522326,
umls-concept:C1522484,
umls-concept:C1704240,
umls-concept:C2698872
|
pubmed:issue |
3
|
pubmed:dateCreated |
1997-3-31
|
pubmed:abstractText |
We analyzed data on 31 children with primary unresectable or metastatic hepatoblastoma (HB) to investigate possible prognostic correlations between the serum level of alpha-fetoprotein (AFP), its changes during treatment, and outcome.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1190-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9060563-Child,
pubmed-meshheading:9060563-Child, Preschool,
pubmed-meshheading:9060563-Feasibility Studies,
pubmed-meshheading:9060563-Female,
pubmed-meshheading:9060563-Hepatoblastoma,
pubmed-meshheading:9060563-Humans,
pubmed-meshheading:9060563-Infant,
pubmed-meshheading:9060563-Liver Neoplasms,
pubmed-meshheading:9060563-Male,
pubmed-meshheading:9060563-Neoplasm Proteins,
pubmed-meshheading:9060563-Pilot Projects,
pubmed-meshheading:9060563-Prognosis,
pubmed-meshheading:9060563-Prospective Studies,
pubmed-meshheading:9060563-Retrospective Studies,
pubmed-meshheading:9060563-Time Factors,
pubmed-meshheading:9060563-Treatment Outcome,
pubmed-meshheading:9060563-alpha-Fetoproteins
|
pubmed:year |
1997
|
pubmed:articleTitle |
Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
|
pubmed:affiliation |
Department of Pediatrics, University of Southern California School of Medicine, Los Angeles, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study
|